eurfilamenT foR diffErEntiaTion Of Pseudo-relapse

• Conditions: G35.1

• Registration Number: DRKS00030784
• Lead Sponsor: niversitätsmedizin der Johannes Gutenberg-Universität Mainz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-11-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. RRMS with subjective disease activity. 2. capable of consent. 3. Over 18 years old

Exclusion Criteria

1. No consent. 2. No RRMS, 3. <18 years old.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Neurofilament concentrations at acute event and EDSS/progression 90d later.

Secondary Outcome Measures

Name	Time	Method
Stratification possibility of NFL with regard to course and affected functional system.